Business Wire

Spectrum Pharmaceuticals Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Corporate Update

Poziotinib NDA accepted for FDA review in previously treated patients with NSCLC harboring HER2 exon 20 insertion mutations, PDUFA date November 24, 2022 Positive poziotinib results in treatment naïve ...
The Motley Fool

Spectrum Pharmaceuticals (SPPI) Q4 2021 Earnings Call Transcript

Thank you for standing by, and welcome to the Spectrum Pharmaceuticals fourth quarter 2021 earnings call. [Operator instructions] As a reminder, today's program may be recorded. I would now like to ...
Nasdaq

Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference

HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that management will ...
Business Insider

Spectrum Appoints New CEO and Provides Outlook for 2021

Boca Raton, Florida, April 05, 2021 (GLOBE NEWSWIRE) -- Spectrum Global Solutions, ( OTC:SGSI ) ( the “Company” ), new CEO Mark Porter, provides an update to SGSI shareholders. I wanted to take the ...
Business Wire

Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference ...